Skip to search formSkip to main contentSkip to account menu

cilansetron

Known as: 10-((2-methyl-1H-imidazol-1-yl)methyl)-5,6,8,9,10,11-hexahydro-4H-pyrido(3,2,1-jk)carbazol-11-one, 4H-Pyrido(3,2,1-jk)carbazol-11(8H)-one, 5,6,9,10-tetrahydro-10-((2-methyl-1H-imidazol-1-yl)methyl)-, (R)- 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

CarbazolesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Effects of serotonin 5-HT(3) receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats.
2007
2007
Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
2007
2007
Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.
We examined the pharmacological profile of ramosetron, a 5-HT(3)-receptor antagonist for irritable bowel syndrome with diarrhea… 
2007
2007
Syndrome de l'intestin irritable : options thérapeutiques actuelles
Review
2007
Review
2007
Pharmacological profile of ramosetron, a novel therapeutic agent for IBS
Abstract.Ramosetron is a potent and selective serotonin (5-HT)3 receptor antagonist that has been shown to affect abnormal… 
Review
2007
Review
2007
Cilansetron in the treatment of diarrhea-predominant irritable bowel syndrome?
Information on the 5-hydroxytryptamine type 3 receptor antagonist cilansetron is scarce and most studies have only been published… 
2005
2005
Cilansetron: a novel, high-affinity 5-HT3 receptor antagonist for irritable bowel syndrome with diarrhea predominance
Irritable bowel syndrome (IBS) is associated with significant morbidity, impaired quality of life, work absenteeism and high… 
2003
2003
5-HT3 receptor antagonists, alosetron and cilansetron, impair mesenteric blood flow in rats
Review
2001
Review
2001
Cilansetron. Solvay.
Cilansetron is a 5-HT3 antagonist tinder development by Solvay Pharmaceuticals as a potential treatment for irritable bowel… 
2000
2000
Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial.
AIMS 5-hydroxytryptamine3 receptor antagonists act antiemetically and slow colonic transit. This study evaluated effects of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)